Wed 26 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| PREDNISOLONE | OPTIPRED 1% OPTHALMIC SUSP. | 1 | 14.45 | Details | |
| TIMOLOL MALEATE | OPTIMOL 0.5% OPHTHALMIC SOLUTION | 0.5 | 31.50 | Details | |
| TIMOLOL MALEATE | OPTIMOL 0.25% OPHTHALMIC SOLUTION | 0.25 | 25.80 | Details | |
| TRETINOIN | OPTIMAL 0.025% GEL | 0.025 | 7 | Details | |
| IOVERSOL | OPTIRAY 240MG-ML SOLUTION FOR IV. Injection* | 240 | 1590 | Details | |
| IOVERSOL | OPTIRAY 300MG-ML SOLUTION FOR IV. Injection* | 300 | 3975 | Details | |
| IOVERSOL | OPTIRAY 300MG-ML SOLUTION FOR IV. Injection | 300 | 3180 | Details | |
| IOVERSOL | OPTIRAY 300MG-ML SOLUTION FOR IV. Injection* | 300 | 1908 | Details | |
| DEXTROSE,SODIUM CHLORIDE,SODIUM CITRATE,POTASSIUM CHLORIDE | ORALITE 28GM SACHETS | 20,3.5,2.9,1.5 | 12.00 | Details | |
| DEXAMETHASONE SODIUM PHOSPHATE | ORADEXON AMPULES 5 MG.-ML. | 5 | 14.15 | Details | |
| DEXAMETHASONE | ORADEXON 1.5 MG TABS | 1.5 | 9 | Details | |
| DEXAMETHASONE | ORADEXON 0.5 MG TABS | 0.5 | 6.3 | Details | |
| POLIOMYELITIS VACCINE | OPVERO | 175.5 | Details | ||
| POLIOMYELITIS VACCINE | OPVERO | 87.75 | Details | ||
| ANTAZOLINE HYDROCHLORIDE,TETRAHYDROZOLINE | OPTIZOLIN OPTHALMIC SOLUTION | 0.5,0.4 | 9.00 | Details | |
| SUMATRIPTAN | ORATAB 100 mg | 100 | 128.6 | Details | |
| IOVERSOL | OPTIRAY 350MG-ML SOLUTION FOR IV. Injection* | 350 | 4637.5 | Details | |
| IOVERSOL | OPTIRAY 350MG-ML SOLUTION FOR IV. Injection* | 350 | 3710 | Details | |
| IOVERSOL | OPTIRAY 350MG-ML SOLUTION FOR IV. Injection* | 350 | 2226 | Details | |
| IOVERSOL | OPTIRAY 320MG-ML SOLUTION FOR IV. Injection* | 320 | 3392 | Details |
5.23% of users said yes from 172 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.